Study of Low-Dose Cytarabine in Combination With Arsenic Trioxide, Compared With Low-Dose Cytarabine Alone, for the Treatment of Elderly Patients With Acute Myeloid Leukemia

This study is ongoing, but not recruiting participants.

Study NCT00513305 Information provided by Cephalon

First Received: August 6, 2007 Last Updated: June 30, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	February 2011
Estimated Primary Completion Date:	June 2009 (Final data collection date for primary outcome measure)